Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes

por Jain, S, Ochsenbauer, C, Kappes, JC, Rosenthal, KL
Publicado 2012

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes

por Matyas, GR, Wieczorek, L, Beck, Z, Ochsenbauer-Jambor, C, Kappes, JC, Michael, NL, Polonis, VR, Alving, CR
Publicado 2009

P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones

por Siddiqui, AA, King, DF, Buffa, V, Fischetti, L, Ochsenbauer-Jambor, C, Gao, Y, Krebs, KC, Kappes, JC, Arts, EJ, Shattock, RJ
Publicado 2009

P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific

por Wieczorek, L, Brown, BK, Wesberry, M, Ochsenbauer-Jambor, C, Kappes, JC, Lora, N, Gillis, A, Nzodom, C, Molnar, S, Michael, NL, Montefiori, D, Polonis, VR
Publicado 2009

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays

por Brown, BK, Lombardi, K, Bryson, M, Currier, J, Thelian, D, Wieczorek, L, Kijak, G, Kappes, JC, Ochsenbauer-Jambor, C, Michael, NL, Montefiori, D, Polonis, VR
Publicado 2009

S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers

por Freel, SA, Chattopadhyay, PK, Lamoreaux, L, Zarkowsky, D, Overman, RG, Ochsenbauer-Jambor, C, Kappes, JC, Cunningham, CK, Denny, TN, Weinhold, KJ, Ferrari, G, Koup, RA, Graham, BS, Haynes, BF, Roederer, M, Tomaras, GD
Publicado 2009